OUTCOMES AND PROGNOSTIC FACTORS OF PULMONARY ARTERIAL HYPERTENSION PATIENTS UNDERGOING EMERGENT ENDOTRACHEAL INTUBATION

TOPIC: Critical Care TYPE: Original Investigations PURPOSE: Management of critically sick patients with pulmonary arterial hypertension (PAH) is challenging and published data indicate increased intensive care unit (ICU) mortality in this population. Unfortunately, we do not have a full understanding of key weaknesses in managing critically ill PAH patients, and the identification of interventions that could lead to improved survival in PAH patients is largely missing. In this analysis, comparing a PAH cohort to a matched cohort of non-PAH patients, we evaluate the impact of emergent endotracheal intubation on short- and long-term outcomes in PAH. METHODS: Retrospective analysis of medical records of adult patients from a large academic center with groups 1 and 3 PAH who underwent emergent intubation in the period 2005-2021. The control group was composed of non-PAH patients who underwent emergent intubation over the same timeframe and were matched by Charlson comorbidity index (CCI) with the PAH cohort. Primary outcome was short-term mortality. Logistic regressions with propensity score weighting were used and p-values of <0.05 were considered statistically significant. RESULTS: We identified 48 PAH and 110 non-PAH CCI-matched patients. Combined cohort mean age was 55.2±13.2, 53% were female and 53% were Caucasian. Major differences between groups were corrected by propensity score weighting. Intubation in the PAH cohort was not associated with increased 24-hour mortality (OR 1.46, 95%CI 0.35-6.09, P=0.59), but was associated with death during hospital admission (OR 4.80, 95%CI 1.50-15.3, P=0.008). Within 24 hours post-intubation, PAH patients experienced more frequent acute kidney injury (43.5% vs 19.8%, P=0.006) and required a higher number of vasopressors (1.69±1.30 vs 1.04±1.01, P=0.004) than non-PAH patients. At 24 hours post-intubation, mean FiO2 (66%±22% vs 49%±21% in non-PAH, P=0.001) were higher in PAH patients. Inability to establish adequate ventilation following intubation was associated with mortality within the PAH cohort (change in PaCO2 +5.14±16.1 in non-survivors vs -18.7±28.0 in survivors, P=0.007). CONCLUSIONS: Our findings provide evidence for worsened outcomes in mechanically ventilated PAH patients in comparison to similar patients without PAH. More importantly, we show that the first 24 hours following intubation in the PAH group represent a particularly vulnerable period which may be crucial for their long-term outcomes. CLINICAL IMPLICATIONS: PAH patients represent a particularly vulnerable population in critical care settings. Emergent endotracheal intubation exposes these patients to increased risk of hemodynamic and respiratory deterioration which further impacts their outcomes. Our findings suggest that particular attention needs to be directed on PAH patients at the time of endotracheal intubation and early, post-intubation interventions may be of crucial relevance to improve survival in this population of patients. DISCLOSURES: No relevant relationships by Igor Barjaktarevic, source=Web Response No relevant relationships by Andrew Hong, source=Web Response No relevant relationships by Joyce Lee, source=Web Response No relevant relationships by Rajan Saggar, source=Web Response No relevant relationships by William Toppen, source=Web Response